Zhu Jinlong, Yu Pei, Zhang Xiaoying, Li Xiaoming, Huang Jiaming, Zhao Shumin, Ruan Qingyan, He Yibo, Zhou Yang, Bao Kunming, Xiu Jiaming, Deng Lin, Liu Yunchen, Liu Yong, Chen Shiqun, Chen Kaihong, Chen Liling
Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
The Third Clinical Medical College, Fujian Medical University, Fuzhou, China.
Ren Fail. 2025 Dec;47(1):2474204. doi: 10.1080/0886022X.2025.2474204. Epub 2025 Mar 24.
Inflammation is a key contributor to contrast-induced acute kidney injury (CI-AKI), yet its predictive role remains unclear. The systemic immune-inflammation index (SII) is a novel inflammatory biomarker, but its association with CI-AKI risk in coronary artery disease (CAD) patients undergoing coronary angiography is not well established. This study aimed to evaluate the relationship between preoperative SII and CI-AKI in a large multicenter cohort.
This retrospective cohort study analyzed CAD patients from five tertiary hospitals in China (2007-2020). Patients were stratified into SII tertiles, and multivariable logistic regression, restricted cubic splines (RCS), and two-piecewise logistic regression models were employed to assess the association between SII and CI-AKI risk.
Among 30,822 patients, 3,246 (10.5%) developed CI-AKI. Higher preoperative SII levels were associated with increased CI-AKI risk ([SII-M vs. SII-L]: OR = 1.22, 95% CI [1.09-1.36], = 0.001; [SII-H vs. SII-L]: OR = 1.70, 95% CI [1.53-1.90], < 0.001). RCS analysis demonstrated a nonlinear relationship (p for nonlinearity = 0.008). The inflection point was at 19.12 × 10/L. Below this inflection point, each 100-unit increase in SII correlated with a 5% higher CI-AKI risk (OR = 1.05, 95% CI [1.04-1.06], < 0.001), while no significant association was observed above this level.
Preoperative SII may be an independent predictor of CI-AKI risk in CAD patients undergoing undergoing coronary angiography, demonstrating a nonlinear dose-response relationship with a significant threshold effect. These findings suggest that SII may serve as a useful biomarker for early CI-AKI risk stratification in clinical practice.
炎症是造影剂诱导的急性肾损伤(CI-AKI)的关键促成因素,但其预测作用仍不明确。全身免疫炎症指数(SII)是一种新型炎症生物标志物,但其与接受冠状动脉造影的冠心病(CAD)患者发生CI-AKI风险的关联尚未明确确立。本研究旨在评估大型多中心队列中术前SII与CI-AKI之间的关系。
这项回顾性队列研究分析了中国五家三级医院(2007 - 2020年)的CAD患者。将患者按SII三分位数分层,并采用多变量逻辑回归、受限立方样条(RCS)和两段式逻辑回归模型评估SII与CI-AKI风险之间的关联。
在30822例患者中,3246例(10.5%)发生了CI-AKI。术前较高的SII水平与CI-AKI风险增加相关([SII-M vs. SII-L]:OR = 1.22,95%CI[1.09 - 1.36],P = 0.001;[SII-H vs. SII-L]:OR = 1.70,95%CI[1.53 - 1.90],P < 0.001)。RCS分析显示存在非线性关系(非线性P = 0.008)。拐点为19.12×10⁹/L。在该拐点以下,SII每增加100个单位,CI-AKI风险增加5%(OR = 1.05,95%CI[1.04 - 1.06],P < 0.001),而在此水平以上未观察到显著关联。
术前SII可能是接受冠状动脉造影的CAD患者发生CI-AKI风险的独立预测指标,呈现出非线性剂量反应关系且具有显著的阈值效应。这些发现表明SII可能作为临床实践中早期CI-AKI风险分层的有用生物标志物。